chlormethiazole has been researched along with Apoplexy in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 14 (70.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Wang, LN; Zhang, J | 1 |
| Liu, J; Wang, LN | 2 |
| Ji, X; Liu, J; Ma, X; Wang, LN | 1 |
| Carlsson, KC; Hooker, AC; Karlsson, MO; Savić, RM | 1 |
| Lutsep, HL; Vaishnav, A | 1 |
| Marshall, JW; Ridley, RM | 1 |
| Green, AR; Marshall, JW; Ridley, RM | 1 |
| Ashwood, T; Ekblom, M; Jonsson, EN; Karlsson, MO; Lyden, P; Odergren, T; Zingmark, PH | 1 |
| Hess, DC | 1 |
| Caster, O; Jonsson, EN; Nyberg, J; Ribbing, J | 1 |
| Bankhead, C | 1 |
| Arboix, A; Ashwood, T; Díez-Tejedor, E; Grossman, E; Leys, D; Teitelbaum, J; Wahlgren, NG | 1 |
| Baker, HF; Cross, AJ; Green, AR; Jackson, DM; Marshall, JW; Ridley, RM | 1 |
| Cross, AJ; Gabrielsson, J; Green, AR; Hainsworth, AH; Jones, JA; Lambert, DG; Murray, TK; Nelson, RM; Richards, DA | 1 |
| Albers, G; Ashwood, T; Jacoby, M; Lyden, P; Mazzeo, P; Nordlund, A; Odergren, T; Schim, J | 1 |
| Ashwood, T; Atkinson, RP; Claesson, L; Levin, K; Lyden, P; Ng, K; Odergren, T; Rajput, A; Salazar-Grueso, E; Shuaib, A; Wechsler, L | 1 |
| Hankey, GJ | 1 |
| Sareen, D | 1 |
7 review(s) available for chlormethiazole and Apoplexy
| Article | Year |
|---|---|
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
Topics: Acute Disease; Chlormethiazole; Diazepam; Disorders of Excessive Somnolence; GABA Agonists; gamma-Aminobutyric Acid; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Rhinitis; Stroke | 2018 |
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
Topics: Chlormethiazole; Diazepam; GABA Agonists; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Stroke | 2013 |
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
Topics: Acute Disease; Chlormethiazole; Diazepam; Disorders of Excessive Somnolence; GABA Agonists; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Rhinitis; Stroke | 2014 |
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
Topics: Acute Disease; Chlormethiazole; Diazepam; Disorders of Excessive Somnolence; GABA Agonists; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Rhinitis; Stroke | 2016 |
GABA agonist: clomethiazole.
Topics: Chlormethiazole; GABA Modulators; GABA-A Receptor Agonists; Humans; Neuroprotective Agents; Stroke | 2002 |
Assessment of cognitive and motor deficits in a marmoset model of stroke.
Topics: Animals; Behavior, Animal; Benzenesulfonates; Callithrix; Chlormethiazole; Cognition; Disease Models, Animal; Female; Male; Motor Activity; Neuroprotective Agents; Nitrogen Oxides; Psychomotor Performance; Pyridines; Recovery of Function; Stroke | 2003 |
Neuroprotective agents in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles | 2002 |
4 trial(s) available for chlormethiazole and Apoplexy
| Article | Year |
|---|---|
Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Chlormethiazole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Male; Middle Aged; Regression Analysis; Stroke | 2003 |
Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients.
Topics: Acute Disease; Aged; Chlormethiazole; Female; Humans; Infusions, Intravenous; Intracranial Hemorrhages; Male; Middle Aged; Neuroprotective Agents; Stroke | 2000 |
The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results.
Topics: Acute Disease; Aged; Brain Ischemia; Chlormethiazole; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Neuroprotective Agents; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2001 |
Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results.
Topics: Acute Disease; Adult; Aged; Brain Ischemia; Chlormethiazole; Double-Blind Method; Female; GABA Modulators; Humans; Male; Middle Aged; Neuroprotective Agents; Stroke; Time Factors | 2002 |
9 other study(ies) available for chlormethiazole and Apoplexy
| Article | Year |
|---|---|
Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision making.
Topics: Algorithms; Anticonvulsants; Chlormethiazole; Computer Simulation; Decision Making; Decision Support Techniques; Epilepsy; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Likelihood Functions; Monitoring, Physiologic; Nonlinear Dynamics; Patients; Poisson Distribution; Pregabalin; Probability; Randomized Controlled Trials as Topic; Software; Stroke | 2009 |
Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures.
Topics: Animals; Behavior, Animal; Benzenesulfonates; Callithrix; Cerebral Cortex; Chlormethiazole; Disease Models, Animal; Drug Administration Routes; Evaluation Studies as Topic; Extinction, Psychological; Motor Activity; Neostriatum; Neuroprotective Agents; Nitrogen Oxides; Pyridines; Space Perception; Stereotaxic Techniques; Stroke; Time Factors | 2003 |
NXY-059: a hopeful sign in the treatment of stroke.
Topics: Animals; Benzenesulfonates; Callithrix; Chlormethiazole; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Fibrinolytic Agents; Free Radical Scavengers; Hemorrhage; Humans; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitrogen Oxides; Pyridines; Randomized Controlled Trials as Topic; Research Design; Rodentia; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2006 |
The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.
Topics: Algorithms; Chlormethiazole; Computer Simulation; Humans; Linear Models; Models, Statistical; Neuroprotective Agents; Nonlinear Dynamics; Pharmacokinetics; Regression Analysis; Stroke | 2007 |
Clomethiazole. Chlormethiazole, Zendra.
Topics: Animals; Chlormethiazole; Drugs, Investigational; Gerbillinae; Humans; Neuroprotective Agents; Stroke | 1999 |
What's new with neuroprotective agents in stroke?
Topics: Animals; Chlormethiazole; Cytidine Diphosphate Choline; Drugs, Investigational; Humans; Neuroprotective Agents; Nootropic Agents; Piperidines; Stroke; Thiazoles | 1999 |
Clomethiazole protects against hemineglect in a primate model of stroke.
Topics: Animals; Attention; Behavior, Animal; Brain; Callithrix; Chlormethiazole; Choice Behavior; GABA Modulators; Movement Disorders; Neuroprotective Agents; Stroke | 2000 |
Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro.
Topics: Animals; Brain Ischemia; Chlormethiazole; Female; gamma-Aminobutyric Acid; Gerbillinae; Glutamic Acid; Hippocampus; Male; Methylamines; Neuroprotective Agents; Rats; Rats, Wistar; Stroke; Thiazoles | 2001 |
Clomethiazole: an unsuccessful bachelor, but perhaps a prosperous married man?
Topics: Acute Disease; Animals; Brain Ischemia; Chlormethiazole; Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Neuroprotective Agents; Stroke; Tissue Plasminogen Activator | 2002 |